LENZ Therapeutics (LENZ) Enterprise Value (2020 - 2026)
LENZ Therapeutics (LENZ) reported Enterprise Value of -$258.4 million for Q1 2026, down 1015.84% year-over-year from $28.2 million in Q1 2025, and up 11.62% quarter-over-quarter from -$292.3 million in Q4 2025.
LENZ Therapeutics (LENZ) Enterprise Value (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Enterprise Value data on file, last reported at -$258.4 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$258.4 million, down 1015.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$258.4 million (down 1015.84% YoY), and the FY2025 annual result was -$292.3 million, down 1342.12% from the prior year.
- Enterprise Value improved to -$258.4 million in Q1 2026 per LENZ's latest filing, from -$292.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$20.3 million in Q4 2024 and troughed at -$339.2 million in Q1 2022.
- A 5-year average of -$194.5 million and a median of -$217.1 million in 2024 frame the typical range for Enterprise Value.
- On a YoY basis, Enterprise Value climbed as much as 88.45% in 2025 and fell as far as 1342.12% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$268.2 million in 2022, then surged by 75.47% to -$65.8 million in 2023, then jumped by 69.19% to -$20.3 million in 2024, then plunged by 1342.12% to -$292.3 million in 2025, then rose by 11.62% to -$258.4 million in 2026.
- Business Quant data shows LENZ's Enterprise Value at -$258.4 million in Q1 2026, -$292.3 million in Q4 2025, and -$202.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | -258.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -258.39 Mn |
| Dec 31, 2025 | -292.35 Mn |
| Sep 30, 2025 | -202.17 Mn |
| Jun 30, 2025 | -37.71 Mn |
| Mar 31, 2025 | -23.16 Mn |
| Dec 31, 2024 | -20.27 Mn |
| Sep 30, 2024 | -217.11 Mn |
| Jun 30, 2024 | -84.14 Mn |
| Mar 31, 2024 | -200.46 Mn |
| Dec 31, 2023 | -65.79 Mn |
| Sep 30, 2023 | -233.99 Mn |
| Jun 30, 2023 | -246.67 Mn |
| Mar 31, 2023 | -202.25 Mn |
| Dec 31, 2022 | -268.23 Mn |
| Sep 30, 2022 | -291.69 Mn |
| Jun 30, 2022 | -322.29 Mn |
| Mar 31, 2022 | -339.18 Mn |
| Dec 31, 2021 | -376.98 Mn |
| Sep 30, 2021 | -394.95 Mn |
| Jun 30, 2021 | -382.11 Mn |